Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: Clinical significance and potential impact on treatment and eradication of HIV/AIDS - Details

author：

Indexed by：

Scopus

Abstract：

Although　oral　combination　antiretroviral　therapy　effectively　clears　plasma　HIV,　patients　on　oral　drugs　exhibit　much　lower　drug　concentrations　in　lymph　nodes　than　blood.　This　drug　insufficiency　is　linked　to　residual　HIV　in　cells　of　lymph　nodes.　While　nanoformulations　improve　drug　solubility,　safety　and　delivery,　most　HIV　nanoformulations　are　intended　to　extend　plasma　levels.　A　stable　nanodrug　combination　that　transports,　delivers　and　accumulates　in　lymph　nodes　is　needed　to　clear　HIV　in　lymphoid　tissues.　This　review　discusses　limitations　of　current　oral　combination　antiretroviral　therapy　and　advances　in　anti-HIV　nanoformulations.　A　＇systems　approach＇　has　been　proposed　to　overcome　these　limitations.　This　concept　has　been　used　to　develop　nanoformulations　for　overcoming　drug　insufficiency,　extending　cell　and　tissue　exposure　and　clearing　virus　for　treating　HIV/AIDS.　©　2016　Future　Medicine　Ltd.

Keyword：

combination antiretroviral therapy; cure for AIDS; HIV; long-acting; lymphatic drug insufficiency; nanoformulation; systems approach; targeted drug delivery

Community：

[ 1 ] [Shao, J.]Cancer Metastasis Alert and Prevention Center, College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350002, China
[ 2 ] [Shao, J.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 3 ] [Kraft, J.C.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 4 ] [Li, B.]Department of Bioengineering, University of Washington, Seattle, WA 98195, United States
[ 5 ] [Yu, J.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 6 ] [Freeling, J.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 7 ] [Koehn, J.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 8 ] [Ho, R.J.Y.]Cancer Metastasis Alert and Prevention Center, College of Chemistry, Fuzhou University, Fuzhou, Fujian, 350002, China
[ 9 ] [Ho, R.J.Y.]Department of Pharmaceutics, University of Washington, Seattle, WA 98195, United States
[ 10 ] [Ho, R.J.Y.]Department of Bioengineering, University of Washington, Seattle, WA 98195, United States

Reprint 's Address：

[Ho, R.J.Y.]Cancer Metastasis Alert and Prevention Center, College of Chemistry, Fuzhou UniversityChina

Email：

rodneyho@u.washington.edu

Show more details

Related Keywords：

Source ：

Nanomedicine

ISSN： 1743-5889

Year： 2016

Issue： 5

Volume： 11

Page： 545-564

4 . 7 2 7

JCR@2016

4 . 7 0 0

JCR@2023

ESI HC Threshold：215

JCR Journal Grade：1

CAS Journal Grade：2

Cited Count：

WoS CC Cited Count：

SCOPUS Cited Count：

ESI Highly Cited Papers on the List： 0 Unfold All

WanFang Cited Count：

Chinese Cited Count：

30 Days PV： 0

Affiliated Colleges：

Get Fulltext

DOI Library Discovery Baidu Scholar Search SCOPUS

Type
Departments

All Years Choose Year From to